Loading...
Results of the SEL-I-METRY phase II trial on resensitization of advanced iodine refractory differentiated thyroid cancer to radioiodine therapy
Wadsley, J Ainsworth, G Coulson, AB Garcez, Kate Moss, L Newbold, K Farnell, K Swain, J Howard, H Beasley, M
Wadsley, J
Ainsworth, G
Coulson, AB
Garcez, Kate
Moss, L
Newbold, K
Farnell, K
Swain, J
Howard, H
Beasley, M
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Files
Keywords
Type
Other
Citation
Wadsley J, Ainsworth G, Coulson AB, Garcez K, Moss L, Newbold K, et al. Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy. Thyroid : official journal of the American Thyroid Association. 2023 SEP 1;33(9):1119-23. PubMed PMID: WOS:001068436200011. English.